The post analyses recent developments in patent and intellectual property, including AstraZeneca’s sale of rights to cancer drugs and South Korea’s new IP backed financing initiatives. It also…
Intellepedia · 31 Dec 2019
This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need,…
Intellepedia · 4 Sep 2015
Astrazeneca has brought a patent infringement case against Aurobindo Pharma over an ANDA filing for Onglyza’s generic version in the US. The dispute centres on the alleged infringement…
Intellepedia · 8 Jan 2015